PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population

Tissue Antigens

Volumn 76, Issue 2, 2010, Pages 119-125

  Morgan, A R ^a,b   Han, D Y ^a,b   Huebner, C ^a,b   Lam, W J ^a,b   Fraser, A G ^a,b   Ferguson, L R ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

Author keywords

Crohn's disease; genetic association; inflammatory bowel disease; PTPN2; PTPN22

Indexed keywords

NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CIGARETTE SMOKING; COLON; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HUMAN; ILEUM; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; YOUNG ADULT;

EID: 77954333748     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01493.x     Document Type: Article

References (46)

1. Shanahan F. Crohn's disease. Lancet 2002 : 359 : 62 9.
2. Mustelin T, Alonso A, Bottinit N et al. Protein tyrosine phosphatases in T cell physiology. Mol Immunol 2004 : 41 : 687 700. (Pubitemid 38824623)
3. Vang T, Miletic AV, Arimura Y et al. Protein tyrosine phosphatases in autoimmunity. Annu Rev Immunol 2008 : 26 : 29 55.
4. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007 : 39 : 857 864.
5. Smyth DJ, Plagnol V, Walker NM et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008 : 359 : 2767 2777.
6. Lee AT, Li W, Liew A et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun 2005 : 6 : 129 133.
7. Orozco G, Sanchez E, Gonzalez-Gay MA et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005 : 52 : 219 224.
8. Zhemakova A, Eerligh P, Wijmenga C et al. Differential association of the PTPN22 coding variant with autoimmune diseases in a Dutch population. Genes Immun 2005 : 6 : 459 461.
9. Smyth D, Cooper JD, Collins JE et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004 : 53 : 3020 3023.
10. Kahles H, Ramos-Lopez E, Lange B et al. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 2005 : 153 : 895 899.
11. Ladner MB, Bottini N, Valdes AM, Noble JA. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol 2005 : 66 : 60 64.
12. Fedetz M, Matesanz F, Caro-Maldonado A et al. The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population. Tissue Antigens 2006 : 67 : 430 433.
13. Kyogoku C, Langefeld CD, Ortmann WA et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet 2004 : 75 : 504 507.
14. Balada E, Villarreal-Tolchinsky J, Ordi-Ros J et al. Multiplex family-based study in systemic lupus erythematosus: association between the R620W polymorphism of PTPN22 and the FcgammaRIIa (CD32A) R131 allele. Tissue Antigens 2006 : 68 : 432 438.
15. Hinks A, Worthington J, Thomson W. The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford) 2006 : 45 : 365 368.
16. Ikari K, Momohara S, Inoue E et al. Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. Rheumatology 2006 : 45 : 1345 1348.
17. Heinonen KM, Nestel FP, Newell EW et al. T-cell protein tyrosine phosphatase deletion results in progressive systematic inflammatory disease. Blood 2004 : 103 : 3457 3464.
18. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 : 447 : 661 678.
19. Parkes M, Barrett JC, Prescott NJ et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007 : 39 : 830 832.
20. Franke A, Balschun T, Karlsen TH et al. Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nat Genet 2008 : 40 : 713 715.
21. Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007 : 39 : 596 603.
22. Libioulle C, Louis E, Hansoul S et al. Novel Crohn's disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007 : 3 : 538 543.
23. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008 : 40 : 955 962.
24. Gearry RB, Richardson A, Frampton CM et al. High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006 : 12 : 936 943.
25. Yap J, Wesley A, Mouat S et al. Paediatric inflammatory bowel disease in New Zealand. N Z Med J 2008 : 121 : 19 34.
26. Tarrant KM, Barclay ML, Frampton CM et al. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype. Am J Gastroenterol 2008 : 103 : 3082 3093.
27. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989 : 170 : 2 6.
28. Jurinke C, van der Boom D, Cantor CR et al. The use of massARRAY technology for high throughput genotyping. Adv Biochem Eng Biotechnol 2002 : 77 : 57 74.
29. Storm N, Darnhofer-Patel B, van der Boom D et al. MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol Biol 2003 : 212 : 241 262.
30. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005 : 76 : 887 893.
31. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997 : 53 : 1253 1261.
32. Storey JD. A direct approach to false discovery rates. J R Stat Soc 2002 : 64 : 479 498.
33. Ihaka R, Gentleman R. R: A language for data analysis and graphics. J Comput Graph Stat 1996 : 5 : 299 314.
34. Dupont WD, Plummer WD Jr. Power and sample size calculations for studies involving linear regression. Control Clin Trials 1998 : 19 : 589 601.
35. Rose JDR, Roberts GM, Williams G et al. Cardiff Crohn's jubilee. The incidence over 50 years. Gut 1988 : 29 : 346 351.
36. Polito JM, Childs B, Mellits ED et al. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996 : 111 : 580 586.
37. Bridger S, Lee JC, Bjarnason I et al. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis. Gut 2002 : 51 : 21 5.
38. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987 : 42 : 241 249.
39. Francus T, Klein RF, Staiano-Coico L et al. Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. J Immunol 1988 : 140 : 1823 1829.
40. George J, Levy Y, Shoenfeld Y. Smoking and immunity: an additional player in the mosaic of autoimmunity. Scand J Immunol 1997 : 45 : 1 6.
41. Scharl M, Paul G, Weber A et al. Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase N2. Gastroenterology 2009 : 137 : 2030 2040.
42. Mankertz J, Schulzke JD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol 2007 : 23 : 379 383.
43. Martin MC, Oliver J, Urcelay E et al. The functional genetic variation in the PTPN22 gene has a negligible effect on the susceptibility to develop inflammatory bowel disease. Tissue Antigens 2005 : 66 : 314 317.
44. Prescott NJ, Fisher SA, Onnie C et al. A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population. Tissue Antigens 2005 : 66 : 318 320.
45. van Oene M, Wintle RF, Liu X et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005 : 52 : 1993 1998.
46. Wagenleiter SE, Klein W, Griga T et al. A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease. Int J Immunogenet 2005 : 32 : 323 324.